3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors

Details for Australian Patent Application No. 2002341881 (hide)

Owner Allergan, Inc.

Inventors Andrews, Steven W.; Wurster, Julie A.; Hull III, Clarence E.; Malone, Thomas; Wang, Edward H.

Agent Davies Collison Cave

Pub. Number AU-B-2002341881

PCT Number PCT/US02/30882

PCT Pub. Number WO2003/027102

Priority 60/325,819 27.09.01 US; 60/325,815 27.09.01 US

Filing date 27 September 2002

Wipo publication date 7 April 2003

Acceptance publication date 8 May 2008

International Classifications

C07D 491/113 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

A61K 31/404 (2006.01)

A61K 31/4162 (2006.01) - condensed with heterocyclic ring systems

A61K 31/428 (2006.01) - condensed with carbocyclic rings

A61K 31/438 (2006.01) - the ring being spiro-condensed with carbocyclic or heterocyclic ring systems

A61K 31/4439 (2006.01)

A61K 31/454 (2006.01)

A61K 31/4725 (2006.01)

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/5377 (2006.01)

A61K 31/541 (2006.01) - Non-condensed thiazines containing further heterocyclic rings

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 17/02 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

Event Publications

27 February 2003 Complete Application Filed

  Priority application(s): 60/325,819 27.09.01 US; 60/325,815 27.09.01 US

26 June 2003 Application Open to Public Inspection

  Published as AU-B-2002341881

8 May 2008 Application Accepted

  Published as AU-B-2002341881

4 September 2008 Standard Patent Sealed

19 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002341882-PACKET ORDERING

2002341880-DIAGNOSIS AND TREATMENT OF VASCULAR DISEASE